Stand Up to Cancer Awards $10 Million to ‘Dream Team’ Focused on Early Detection of Precursor Multiple Myeloma Conditions
Stand Up to Cancer (SU2C) recently awarded $10…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Chip-based Blood Test Might Replace Bone Marrow Biopsies for Myeloma, Scientists Say
Researchers say they have developed a low-cost, reliable, chip-based…
Phase 1 Trial for Investigational Therapy STRO-001 Treats First Myeloma, Lymphoma Patients
A Phase 1 clinical trial testing therapy candidate STRO-001…
New Method of Classifying Malignant Myeloma Cells Improves Outcomes, Study Finds
A new method that selects and isolates malignant myeloma…
P-BCMA-101 Shows Early Effectiveness in First Multiple Myeloma Patients Treated in Phase 1 Trial
P-BCMA-101, Poseida Therapeutics’ CAR T-cell therapy, is safe and…
Seattle Genetics’ Investigational Therapy Fares Well in Multiple Myeloma Animal Models
A new antibody targeting the BCMA protein — called…
